` KMTS (Kestra Medical Technologies Inc) vs S&P 500 Comparison - Alpha Spread

K
KMTS
vs
S&P 500

Over the past 12 months, KMTS has outperformed S&P 500, delivering a return of +22% compared to the S&P 500's +18% growth.

Stocks Performance
KMTS vs S&P 500

Loading
KMTS
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
KMTS vs S&P 500

Loading
KMTS
S&P 500
Difference
www.alphaspread.com

Performance By Year
KMTS vs S&P 500

Loading
KMTS
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Kestra Medical Technologies Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Kestra Medical Technologies Inc
Glance View

Market Cap
1.5B USD
Industry
Health Care

Kestra Medical Technologies Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington. The company went IPO on 2025-03-06. The firm is focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. The company has developed and commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform include the ASSURE WCD, a next generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The ASSURE WCD automatically monitors elevated risk patients and, if needed, delivers a defibrillation shock to return the patient’s heart to normal rhythm. In addition to the ASSURE WCD, its Cardiac Recovery System platform includes a comprehensive suite of fully integrated digital solutions and services.

KMTS Intrinsic Value
6.27 USD
Overvaluation 76%
Intrinsic Value
Price
K
Back to Top